Overview
Eindhoven-based medtech startup Shanx Medtech has raised €24 million in a seed funding round to enhance its in-vitro diagnostic platforms for antibiotic susceptibility testing. The oversubscribed round was led by Borski Fund and included equity, grants, and the Innovatiekrediet. Shanx also secured an €8.85 million contract from the European Commission, bringing its total financing to €24 million. The funding will accelerate the development and market launch of its rapid diagnostic solutions, aimed at improving patient outcomes in real-time.
Products
Loading...
Recent Deals
$25.92M
Investors: Borski Fund
Eindhoven-based medtech startup Shanx Medtech has raised €24 million in a seed funding round to enhance its in-vitro diagnostic platforms for antibiotic susceptibility testing. The oversubscribed round was led by Borski Fund and included equity, grants, and the Innovatiekrediet. Shanx also secured an €8.85 million contract from the European Commission, bringing its total financing to €24 million. The funding will accelerate the development and market launch of its rapid diagnostic solutions, aimed at improving patient outcomes in real-time.